Biotech
-
The light at the end of the tunnel for Awakn Life Sciences addiction treatment by Psychedelic therapeutics
As an investor, I like to look for companies that have tremendous leverage to success. I often write…
-
Will Sixth Wave’s fast and accurate breathalyzer revolutionize global pathogenic virus testing?
I’m hopeful that we will soon see this whole COVID issue become an endemic as opposed to a…
-
Blender Bites is a Smooth(ie) Rapidly Growing Operator in the Frozen Health Food Category
Most people enter the new year full of optimism with thoughts of improving their health and wellness. Arguably…
-
Bristow goes with technology and selects the stock to watch in 2022
Welcome to 2022! I’m cautiously optimistic that this will be the year we get to put Covid in…
-
David Regan on Sona Nanotech’s rapid-result saliva based COVID-19 test
In a recent InvestorIntel interview, Chris Thompson spoke with David Regan, CEO of Sona Nanotech Inc. (CSE: SONA |…
-
Awakn Life Sciences’ new psychedelic drug treatment for alcohol addiction moving to clinical trial
As we all know alcohol addiction is one of the worst addictions in society costing billions per year.…
-
Dr. Allen Davidoff of XORTX Therapeutics’ on developing therapies for kidney diseases and uplisting to the NASDAQ
In a recent InvestorIntel interview, Chris Thompson spoke with Dr. Allen Davidoff, CEO of XORTX Therapeutics Inc. (NASDAQ:…
-
Sona Nanotech is seeking U.S. FDA approval for its rapid COVID-19 saliva test
Much to my chagrin, it appears this damn COVID virus is refusing to let us be. I guess…
